Journal Article10.1148/RADIOLOGY.172.1.2740512
Small, superficial esophageal carcinoma treated with high-dose-rate intracavitary irradiation only
25
TL;DR: Six patients with small, superficial carcinoma of the esophagus were treated with 18-24 Gy of high-dose-rate intracavitary irradiation only, and all patients were examined with an endoscope within 1 month after therapy, and the tumor in all six had disappeared.
read more
Abstract: Six patients with small, superficial carcinoma of the esophagus were treated with 18-24 Gy of high-dose-rate intracavitary irradiation only. All patients were examined with an endoscope within 1 month after therapy, and the tumor in all six had disappeared. However, erosion induced by high-dose-rate intracavitary irradiation was seen in five of the patients. Five of the patients have experienced no local recurrence; endoscopic biopsy showed local recurrence in the remaining patient 7 months after radiation therapy. All patients have survived 6-16 months. Esophageal ulceration induced by intracavitary irradiation occurred in three of the six patients; however, the ulcers have been healing with conservative treatment. This new method of using only high-dose-rate intracavitary irradiation appears to be effective in the patient with small, superficial esophageal carcinoma.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in japan
TL;DR: Further prospective randomized studies are necessary to evaluate the efficacy in tumors with short length and those with shallow invasion, or to assess the usefulness of intraluminal brachytherapy, as additional irradiation in large advanced tumors have been shown to have disappeared by diagnostic imaging after chemoradiotherapy with 60 Gy/6w external irradiation.
95
High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine
TL;DR: From May 1980 through December 1989, 148 patients with thoracic esophageal cancer were treated with high-dose-rate intraluminal brachytherapy (HDRIBT) following external radiotherapy (ERT), and ulceration, stricture, and fistula were found in 42 patients.
93
Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus.
TL;DR: The simplicity of the treatment, which could be completed as a day case procedure and did not cause significant morbidity, commends itself in the palliation of these patients who have poor overall survival and quality of life.
53
External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.
Yasumasa Nishimura,Yasumasa Nishimura,Yoshishige Okuno,Koji Ono,Michihide Mitsumori,Yasushi Nagata,Masahiro Hiraoka +6 more
TL;DR: Clinical results of external beam radiation therapy with or without intraluminal brachytherapy (IBT) for patients with superficial esophageal carcinoma were evaluated retrospectively.
52
High-dose-rate intraluminal brachytherapy (HDRIBT) for esophageal cancer.
TL;DR: High-dose-rate intraluminal brachytherapy for patients with esophageal cancer has been performed with and without external radiotherapy (ERT) in the authors' department since May 1980 and the tumor had disappeared completely in all six patients at the time of first follow-up endoscopic study less than 1 month after treatment.
45